Role of structural and macrocrystalline factors in the desolvation behaviour of cortisone acetate solvates

Journal of Thermal Analysis and Calorimetry

Volumn 90, Issue 1, 2007, Pages 39-47

  Petit, S ^a   Mallet, F ^a   Petit, M N ^a   Coquerel, G ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Crystal structure; Desolvation mechanism; Solid solid transformation; Solvates

Indexed keywords

CRACKS; DIFFERENTIAL SCANNING CALORIMETRY; OPTICAL MICROSCOPY; PYROLYSIS;

CORTISONE ACETATE MONOHYDRATE; DESOLVATION MECHANISM; SOLID-SOLID TRANSFORMATION; SOLVATES;

CRYSTAL STRUCTURE;

EID: 34648820647     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-007-8475-z     Document Type: Article

References (50)

1. Yu. V. Mnyukh, Mol. Cryst. Liq. Cryst., 52 (1979) 163.
2. T. L. Threlfall, Analyst, 120 (1995) 2435.
3. R. Hüttenrauch, S. Fricke and P. Zielke, Pharm. Res., (1985) 302.
4. V. V. Boldyrev, J. Mater. Sci., 39 (2004) 5117.
5. S. Petit and G. Coquerel, Polymorphism in the Pharmaceutical Industry, R. Hilfiker, Ed., Wiley-VCH, Weinheim, Germany 2006, p. 259.
6. R. W. Munn, Chem. Brit., 14 (1978) 231.
7. N. Boudjada, J. Rodriguez-Carvajal, M. Anne and M. Figlarz, J. Solid State Chem., 105 (1993) 211.
8. L. Stoch, J. Thermal Anal., 38 (1992) 131.
9. J.-C. Niepce and G. Watelle-Marion, C. R. Acad. Sci., 276 (1973) 627.
10. A. K. Galwey and G. M. Laverty, J. Chim. Phys., 87 (1990) 1207 and references therein.
11. N. Z. Lyakhov and V. V. Boldyrev, Russ. Chem. Rev., 41 (1972) 919.
12. A. K. Galwey, J. Thermal Anal., 38 (1992) 99.
13. A. K. Galwey, Proc. R. Soc. London A, 441 (1993) 313.
14. A. K. Galwey, Thermochim. Acta, 355 (2000) 181.
15. I. Langmuir, J. Am. Chem. Soc., 38 (1916) 2221.
16. S. R. Byrn, R. R. Pfeiffer, M. Ganey, C. Hoiberg and G. Poochikian, Chem. Mater., 6 (1994) 1148.
17. D. Giron, Thermochim. Acta, 248 (1995) 1.
18. N. Rodriguez-Hornedo and D. Murphy, J. Pharm. Sci., 88 (1999) 651.
19. A. K. Galwey, J. Pharm. Pharmacol., 51 (1999) 879.
20. T. P. Shakhtshneider and V. V. Boldyrev, Reactivity of Molecular Solids, E. Boldyreva, V. V. Boldyrev, Eds, Wiley & Sons, New York 1999, p. 271.
21. P. Van der Sluis and J. Kroon, J. Cryst. Growth, 97 (1989) 645.
22. C. H. Görbitz and H. P. Hersleth, Acta Cryst., B56 (2000) 526.
23. S. R. Byrn, Solid-State Chemistry of Drugs, Academic Press, New York 1982, p. 149.
24. R. K. Khankari and D. J. W. Grant, Thermochim. Acta, 248 (1995) 61.
25. D. Giron, C. Goldbronn, M. Mutz, S. Pfeffer, P. Piechon and P. Schwab, J. Therm. Anal. Cal., 68 (2002) 453.
26. K. R. Morris, Polymorphism in Pharmaceutical Solids, H. G. Brittain, Ed., Marcel Dekker Inc., New York 1999, p. 125.
27. G. A. Stephenson, E. G. Groleau, R. L. Kleemann, W. Xu and D. R. Rigsbee, J. Pharm. Sci., 87 (1998) 536.
28. M. D. Jones, J. C. Hooton, M. L. Dawson, A. R. Ferrie and R. Price, Int. J. Pharm., 313 (2006) 87.
29. H. J. Zhu, Int. J. Pharm., 315 (2006) 18.
30. S. Petit and G. Coquerel, Chem. Mater., 8 (1996) 2247.
31. S. Garnier, S. Petit and G. Coquerel, J. Therm. Anal. Cal., 68 (2002) 489.
32. F. Mallet, S. Petit, S. Lafont, P. Billot, D. Lemarchand and G. Coquerel, J. Therm. Anal. Cal., 73 (2002) 459.
33. F. Mallet, S. Petit, S. Lafont, P. Billot, D. Lemarchand and G. Coquerel, Cryst. Growth Des., 4 (2004) 965.
34. E. S. Rothman and M. E. Wall, J. Am. Chem. Soc., 81 (1959) 411.
35. R. K. Callow and O. Kennard, J. Pharm. Pharmacol., 13 (1961) 723.
36. J. E. Carless, M. A. Moustafa and H. D. C. Rapson, J. Pharm. Pharmacol., 18 (1966) 190.
37. M. Kuhnert-Brandstätter and H. Grimm, Mikrochim. Acta, (1968) 115.
38. R. J. Mesley, J. Pharm. Pharmacol., 20 (1968) 877.
39. K. Shirotani and K. Sekiguchi, Chem. Pharm. Bull., 29 (1981) 2983.
40. J. P. Declercq, G. Germain and M. Van Meerssche, Cryst. Struct. Commun., 1 (1972) 59.
41. J. A. Kanters, A. de Koster, V. J. van Geerestein and L. A. van Dijck, Acta Cryst. C., 41 (1985) 760.
42. V. J. van Geerestein and J. A. Kanters, Acta Cryst. C., 43 (1987) 136.
43. V. J. van Geerestein and J. A. Kanters, Acta Cryst. C., 43 (1987) 936.
44. J. E. Carless, M. A. Moustafa and H. D. C. Rapson, J. Pharm. Pharmacol., 24 (1972) 130P.
45. G. M. Sheldrick, SHELXTL, Release 5.10, (Program for the determination and the refinement of crystal structures), Bruker Analytical X-ray Instruments Inc., Madison, Wisconsin, USA.
46. U. J. Griesser, Polymorphism in the Pharmaceutical Industry (ed. R. Hilfiker), Wiley-VCH, Weinheim, Germany 2006, p. 211.
47. N. N. Petropavlov, J. Cryst. Growth, 52 (1981) 889.
48. J. E. Ricci, The Phase Rule and Heterogeneous Equilibrium, Dover Publications, New York 1966, p. 278.
49. W. Feitknecht, Pure Appl. Chem., 9 (1964) 423.
50. R. Giovanoli, H. R. Oswald and W. Feitknecht, Helv. Chim. Acta, 49 (1966) 1971.